AI assistant
CASTLE BIOSCIENCES INC — Director's Dealing 2021
Feb 25, 2021
32601_dirs_2021-02-25_a0e59d9d-4fc5-4d23-b9ec-b494712083e5.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CASTLE BIOSCIENCES INC (CSTL)
CIK: 0001447362
Period of Report: 2021-02-23
Reporting Person: BRADBURY DANIEL (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-02-23 | Common Stock | S | 400 | $73.41 | Disposed | 365593 | Indirect |
| 2021-02-23 | Common Stock | S | 1200 | $77.41 | Disposed | 364393 | Indirect |
| 2021-02-23 | Common Stock | S | 900 | $78.429 | Disposed | 363493 | Indirect |
| 2021-02-23 | Common Stock | S | 1770 | $79.619 | Disposed | 361723 | Indirect |
| 2021-02-23 | Common Stock | S | 834 | $80.752 | Disposed | 360889 | Indirect |
| 2021-02-23 | Common Stock | S | 2196 | $81.82 | Disposed | 358693 | Indirect |
| 2021-02-23 | Common Stock | S | 200 | $82.30 | Disposed | 358493 | Indirect |
| 2021-02-24 | Common Stock | S | 704 | $78.892 | Disposed | 357789 | Indirect |
| 2021-02-24 | Common Stock | S | 600 | $80.058 | Disposed | 357189 | Indirect |
| 2021-02-24 | Common Stock | S | 681 | $81.528 | Disposed | 356508 | Indirect |
| 2021-02-24 | Common Stock | S | 1079 | $82.632 | Disposed | 355429 | Indirect |
| 2021-02-24 | Common Stock | S | 1420 | $83.126 | Disposed | 354009 | Indirect |
| 2021-02-24 | Common Stock | S | 770 | $84.352 | Disposed | 353239 | Indirect |
| 2021-02-24 | Common Stock | S | 997 | $86.095 | Disposed | 352242 | Indirect |
| 2021-02-24 | Common Stock | S | 849 | $86.917 | Disposed | 351393 | Indirect |
| 2021-02-24 | Common Stock | S | 400 | $88.388 | Disposed | 350993 | Indirect |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 157781 | Indirect |
| Common Stock | 157804 | Indirect |
Footnotes
F1: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by BioBrit, LLC (the "LLC") on September 5, 2020.
F2: This transaction was executed in multiple trades at prices ranging from $73.010 to $73.810, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F3: Held by the LLC, of which the Reporting Person is the managing member and has voting and investment power over the shares.
F4: This transaction was executed in multiple trades at prices ranging from $76.960 to $77.685, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F5: This transaction was executed in multiple trades at prices ranging from $78.010 to $78.935, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F6: This transaction was executed in multiple trades at prices ranging from $79.190 to $80.140, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F7: This transaction was executed in multiple trades at prices ranging from $80.200 to $81.050, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F8: This transaction was executed in multiple trades at prices ranging from $81.260 to $82.140, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F9: This transaction was executed in multiple trades at prices ranging from $78.560 to $79.390, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F10: This transaction was executed in multiple trades at prices ranging from $79.860 to $80.570, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F11: This transaction was executed in multiple trades at prices ranging from $80.880 to $81.860, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F12: This transaction was executed in multiple trades at prices ranging from $81.880 to $82.800, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F13: This transaction was executed in multiple trades at prices ranging from $82.930 to $83.700, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F14: This transaction was executed in multiple trades at prices ranging from $84.010 to $84.990, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F15: This transaction was executed in multiple trades at prices ranging from $85.440 to $86.420, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F16: This transaction was executed in multiple trades at prices ranging from $86.550 to $87.200, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F17: This transaction was executed in multiple trades at prices ranging from $88.060 to $88.855, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F18: Held by Daniel Bradbury Irrecovable Descendant's Trust of which the reporting person and his spouse are trustees and their children are beneficiaries.
F19: Held by Annette Bradbury Irrecovable Descendant's Trust of which the reporting person and his spouse are trustees and their children are beneficiaries.